GlassScriptPhysician profile
Katherine K Boyd
NPI 1639253297
$1,523.74
in general payments reported to CMS, 2019-2025
18 companies · $232 in 2025
The $232 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $475 · 2020: $331 · 2021: $171 · 2022: $93.44 · 2023: $128 · 2024: $92.70 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $439 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $439.23 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $303.83 | 2019-2023 | Lo Loestrin Fe |
| Pfizer INC. | $175.92 | 2019-2023 | |
| Lupin INC. | $163.91 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $149.85 | 2025 | Myfembree |
| Therapeuticsmd, INC. | $106.48 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $92.94 | 2021-2025 | |
| Medtronic USA, INC. | $82.60 | 2019 | |
| Millicent US INC | $77.19 | 2020-2024 | Intrarosa |
| Amag Pharmaceuticals, INC. | $74.73 | 2019-2020 | |
| Hologic Sales and Service, LLC | $58.63 | 2024 | Aptima |
| Astellas Pharma US INC | $42.46 | 2024-2025 | Veozah |
| Ironwood Pharmaceuticals, INC | $40.90 | 2020 | |
| Allergan, INC. | $36.18 | 2019-2020 | |
| Avion Pharmaceuticals | $35.91 | 2020-2021 | |
| Axsome Therapeutics, INC. | $24.52 | 2025 | Auvelity |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $23.76 | 2019 | |
| Exact Sciences Corporation | $17.85 | 2025 | The Cologuard Plus Collection Kit |
| Evofem Biosciences, INC. | $16.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.